Please enable JavaScript
Powered by Benchmark International Archives - Page 654 of 1922 - Matribhumi Samachar English
Saturday, January 31 2026 | 04:04:50 AM
Home / International (page 654)

International

Benton Increases Private Placement to $2,400,000 and Files for Conditional Approval

Thunder Bay, Ontario–(Newsfile Corp. – September 23, 2025) – Benton Resources Inc. (TSXV: BEX) (“Benton” or the “Company”) is pleased to announce that due to strong investor demand it has increased its non-brokered private placement, previously announced on September 17, 2025 (the “Financing”) to up to 43,636,364 $0.055 units (“Units”), for …

Read More »

Three Valley Copper Corp. Announces Extension of Loan Agreement

Toronto, Ontario–(Newsfile Corp. – September 23, 2025) – Three Valley Copper Corp. (TSXV: TVC) (the “Company“) is pleased to announce, further to its press release dated July 24, 2025, that it has formally extended the maturity date of the secured convertible promissory note dated July 25, 2023 (the “Promissory Note“) …

Read More »

Neural’s Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich

Toronto, Ontario–(Newsfile Corp. – September 23, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) (“Neural” or the “Company“), an ethnobotanical drug discovery company focused on developing therapeutic solutions for substance use disorders, together with CWE European Holdings Inc. (“CWE“), operating as Hanf.com, one of Germany’s leading CBD retailers, is …

Read More »

Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell(TM)) Across Multiple Ischemic and Vascular Indications Simultaneously

Calgary, Alberta–(Newsfile Corp. – September 23, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and …

Read More »

CSE Bulletin: Delist – Asante Gold Corporation (ASE)

Toronto, Ontario–(Newsfile Corp. – Le 23 septembre/September 2025) – The common shares of Asante Gold Corporation (the ‘Issuer’) will be delisted from the CSE at market close, September 23, 2025. The Issuer will continue to trade on the TSX Venture Exchange. _________________________________ Les actions ordinaires de Asante Gold Corporation (l’« …

Read More »